Seeing Is Believing

Currently out of the existing stock ratings of Emily Field, 43 are a BUY (53.75%), 27 are a HOLD (33.75%), 10 are a SELL (12.5%).
Analyst Emily Field, currently employed at BARCLAYS, carries an average stock price target met ratio of 53.03% that have a potential upside of 24.84% achieved within 278 days.
Emily Field’s has documented 138 price targets and ratings displayed on 12 stocks. The coverage is on Healthcare, Basic Materials, Consumer Cyclical sectors.
Most recent stock forecast was given on NVO, Novo Nordisk A/S at 30-Jul-2025.
Analyst best performing recommendations are on GLPG (GALAPAGOS NV ADR).
The best stock recommendation documented was for GLPG (GALAPAGOS NV ADR) at 3/2/2021. The price target of $82.77 was fulfilled within 1 day with a profit of $1.59 (1.88%) receiving and performance score of 18.85.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Nov-2017
$1150
$165.61 (16.82%)
$1150
Buy Since 03-Jul-2025
$1250
$265.61 (26.98%)
$1230
12 days ago
(31-Aug-2026)
2/4 (50%)
$218.34 (21.16%)
192
Hold Since 06-Nov-2023
$1400
$415.61 (42.22%)
$910
17 days ago
(26-Aug-2026)
7/8 (87.5%)
$352.9 (33.70%)
218
Buy Since 14-Sep-2018
$1415
$430.61 (43.74%)
$1260
17 days ago
(26-Aug-2026)
21/26 (80.77%)
$367.9 (35.14%)
204
Buy Since 25-Aug-2025
$1100
$115.61 (11.74%)
$1025
25 days ago
(18-Aug-2026)
6/7 (85.71%)
$107.01 (10.78%)
74
What Year was the first public recommendation made by Emily Field?